Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boris Draznin

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
Journal of European CME|December 6, 2021
Virtual patient simulation platforms challenging traditional CME: Identification of gaps in knowledge in the management of Type 2 diabetes and HyperlipidaemiaIgal Iancu, Eugene Pozniak, Boris Draznin
Journal of CME|March 27, 2023
Virtual Patient Simulation Offers an Objective Assessment of CME Activity by Improving Clinical Knowledge and the Levels of Competency of Healthcare ProvidersIgal Iancu, Liron Zehavi, Boris Draznin
Hospital Practice (1995)|May 18, 2013
Practical approach to management of inpatient hyperglycemia in select patient populationsCecilia C Low Wang, Boris Draznin
Journal of Hospital Medicine|March 10, 2011
Pilot study of using neutral protamine Hagedorn insulin to counteract the effect of methylprednisolone in hospitalized patients with diabetesStacey A Seggelke, Joanna Gibbs, Boris Draznin
Diabetes|September 30, 2003
Insulin affects vascular smooth muscle cell phenotype and migration via distinct signaling pathwaysCecilia C Low Wang, Inga Gurevich, Boris Draznin
American Journal of Hypertension|April 4, 2006
Early growth response gene-1 expression in vascular smooth muscle cells effects of insulin and oxidant stressCecilia C Low Wang, Girish Sharma, Boris Draznin
Diabetes|October 27, 2004
Molecular mechanisms of insulin resistance that impact cardiovascular biologyCecilia C Low Wang, Marc L Goalstone, Boris Draznin
Diabetes Care|November 23, 2013
Response to comment on: Draznin et al. Pathways to quality inpatient management of hyperglycemia and diabetes: a call to action. Diabetes Care 2013;36:1807-1814Boris Draznin, Janice Gilden, Sherita H Golden, et al.
Endocrinology|October 25, 2008
Rescuing 3T3-L1 adipocytes from insulin resistance induced by stimulation of Akt-mammalian target of rapamycin/p70 S6 kinase (S6K1) pathway and serine phosphorylation of insulin receptor substrate-1: effect of reduced expression of p85alpha subunit of phosphatidylinositol 3-kinase and S6K1 kinaseRebecca Adochio, J Wayne Leitner, Reed Hedlund, et al.
Biochemical and Biophysical Research Communications|December 10, 2008
Knockdown of JNK rescues 3T3-L1 adipocytes from insulin resistance induced by mitochondrial dysfunctionToni Kim, J Wayne Leitner, Rebecca Adochio, et al.
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
Journal of European CME|December 6, 2021
Virtual patient simulation platforms challenging traditional CME: Identification of gaps in knowledge in the management of Type 2 diabetes and HyperlipidaemiaIgal Iancu, Eugene Pozniak, Boris Draznin
Journal of CME|March 27, 2023
Virtual Patient Simulation Offers an Objective Assessment of CME Activity by Improving Clinical Knowledge and the Levels of Competency of Healthcare ProvidersIgal Iancu, Liron Zehavi, Boris Draznin
Hospital Practice (1995)|May 18, 2013
Practical approach to management of inpatient hyperglycemia in select patient populationsCecilia C Low Wang, Boris Draznin
Journal of Hospital Medicine|March 10, 2011
Pilot study of using neutral protamine Hagedorn insulin to counteract the effect of methylprednisolone in hospitalized patients with diabetesStacey A Seggelke, Joanna Gibbs, Boris Draznin
Diabetes|September 30, 2003
Insulin affects vascular smooth muscle cell phenotype and migration via distinct signaling pathwaysCecilia C Low Wang, Inga Gurevich, Boris Draznin
American Journal of Hypertension|April 4, 2006
Early growth response gene-1 expression in vascular smooth muscle cells effects of insulin and oxidant stressCecilia C Low Wang, Girish Sharma, Boris Draznin
Diabetes|October 27, 2004
Molecular mechanisms of insulin resistance that impact cardiovascular biologyCecilia C Low Wang, Marc L Goalstone, Boris Draznin
Diabetes Care|November 23, 2013
Response to comment on: Draznin et al. Pathways to quality inpatient management of hyperglycemia and diabetes: a call to action. Diabetes Care 2013;36:1807-1814Boris Draznin, Janice Gilden, Sherita H Golden, et al.
Endocrinology|October 25, 2008
Rescuing 3T3-L1 adipocytes from insulin resistance induced by stimulation of Akt-mammalian target of rapamycin/p70 S6 kinase (S6K1) pathway and serine phosphorylation of insulin receptor substrate-1: effect of reduced expression of p85alpha subunit of phosphatidylinositol 3-kinase and S6K1 kinaseRebecca Adochio, J Wayne Leitner, Reed Hedlund, et al.
Biochemical and Biophysical Research Communications|December 10, 2008
Knockdown of JNK rescues 3T3-L1 adipocytes from insulin resistance induced by mitochondrial dysfunctionToni Kim, J Wayne Leitner, Rebecca Adochio, et al.
Pageof 7